Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy

BACKGROUND: VeriStrat test is a serum assay which uses a mass spectrometry (MS)-based proteomic signature derived from machine learning. It is currently used as a prognostic marker for patients with non-small cell lung cancer (NSCLC) receiving chemotherapy. However, little is known about its role fo...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Transl Lung Cancer Res
Main Authors: Chae, Young Kwang, Kim, Won Bin, Davis, Andrew A., Park, Lee Chun, Anker, Jonathan F., Simon, Nicholas I., Rhee, Kyunghoon, Song, Junho, Cho, Anderson, Chang, Sangmin, Ko, Taeyeong, Oh, Michael, Bhave, Manali, Viveiros, Pedro
Format: Artigo
Sprog:Inglês
Udgivet: AME Publishing Company 2020
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481587/
https://ncbi.nlm.nih.gov/pubmed/32953481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-148
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker